Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models—I. 6-[ 3H]-5-fluorouracil
The differential tissue distribution and urinary excretion of small intravenous doses (4 μg kg −1) of 6-[ 3H]-5-fluorouracil have been studied in two strains of mice bearing transplantable tumors. The subcutaneous Lewis Lung carcinoma and the solid Ehrlich Ascites carcinoma both retained less than 1...
Gespeichert in:
Veröffentlicht in: | International journal of nuclear medicine & biology 1979, Vol.6 (2), p.97-101 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 101 |
---|---|
container_issue | 2 |
container_start_page | 97 |
container_title | International journal of nuclear medicine & biology |
container_volume | 6 |
creator | Abrams, D.N. Knaus, E.E. Wiebe, L.I. |
description | The differential tissue distribution and urinary excretion of small intravenous doses (4 μg kg
−1) of 6-[
3H]-5-fluorouracil have been studied in two strains of mice bearing transplantable tumors. The subcutaneous Lewis Lung carcinoma and the solid Ehrlich Ascites carcinoma both retained less than 1.5% of the dose, and for all tissues assayed the tumor: blood ratios for radioactivity were 11:1 or less. Approximately 75% of the injected dose was excreted during the first 12 h. Urinary excretion was resolved using a two-compartmental model. The half-life of the fast component was just over 1 h while that for the slow component was in excess of 10 days. |
doi_str_mv | 10.1016/0047-0740(79)90003-2 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_74699692</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0047074079900032</els_id><sourcerecordid>74699692</sourcerecordid><originalsourceid>FETCH-LOGICAL-c271t-ccd97a6d9ae8f7a3acf99593b5ff96fa45e3e6d3fbf5135ea7705cf6869080a43</originalsourceid><addsrcrecordid>eNp9kLlKBTEUhlO4L29gkUq0GM1syaQRRNxAsNFKJJxJTiCamVyTG8HOh_AJfRLnekWwsTrwb3A-QvZKdlSykh8z1oiCiYYdCHkoGWN1Ua2QzV95g2yl9MRY1TUtXydrjeiEqDZJvstDiDTP5vCMNFgawbjgoUePhs7eohuccSPSHhImCuMfcczaY0jOTJYbJ9cN4OkQDPr0-f5xfUR58UDrq8eiLazPIYYcQTu_Q1Yt-IS7P3eb3F-c351dFTe3l9dnpzeFrkQ5L7Q2UgA3ErCzAmrQVspW1n1rreQWmhZr5Ka2vW3LukUQgrXa8o5L1jFo6m2yv9ydxfCSMc3V4JJG72HEkJMSDZeSy2oKNsugjiGliFbNpichvqmSqQVgtSCpFiSVkOobsFrU9n72cz-g-S0t6U72ydKecOCrw6iSdjhqNC6inisT3P_7Xy85jpA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>74699692</pqid></control><display><type>article</type><title>Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models—I. 6-[ 3H]-5-fluorouracil</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Abrams, D.N. ; Knaus, E.E. ; Wiebe, L.I.</creator><creatorcontrib>Abrams, D.N. ; Knaus, E.E. ; Wiebe, L.I.</creatorcontrib><description>The differential tissue distribution and urinary excretion of small intravenous doses (4 μg kg
−1) of 6-[
3H]-5-fluorouracil have been studied in two strains of mice bearing transplantable tumors. The subcutaneous Lewis Lung carcinoma and the solid Ehrlich Ascites carcinoma both retained less than 1.5% of the dose, and for all tissues assayed the tumor: blood ratios for radioactivity were 11:1 or less. Approximately 75% of the injected dose was excreted during the first 12 h. Urinary excretion was resolved using a two-compartmental model. The half-life of the fast component was just over 1 h while that for the slow component was in excess of 10 days.</description><identifier>ISSN: 0047-0740</identifier><identifier>DOI: 10.1016/0047-0740(79)90003-2</identifier><identifier>PMID: 478772</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Carcinoma, Ehrlich Tumor - metabolism ; Carcinoma, Ehrlich Tumor - urine ; Fluorouracil - metabolism ; Fluorouracil - urine ; Half-Life ; Lung Neoplasms - metabolism ; Lung Neoplasms - urine ; Male ; Mice ; Models, Biological ; Neoplasm Transplantation ; Neoplasms, Experimental - metabolism ; Neoplasms, Experimental - urine ; Pyrimidine Nucleosides - metabolism ; Pyrimidine Nucleosides - urine ; Time Factors ; Tritium</subject><ispartof>International journal of nuclear medicine & biology, 1979, Vol.6 (2), p.97-101</ispartof><rights>1979</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c271t-ccd97a6d9ae8f7a3acf99593b5ff96fa45e3e6d3fbf5135ea7705cf6869080a43</citedby><cites>FETCH-LOGICAL-c271t-ccd97a6d9ae8f7a3acf99593b5ff96fa45e3e6d3fbf5135ea7705cf6869080a43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/478772$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abrams, D.N.</creatorcontrib><creatorcontrib>Knaus, E.E.</creatorcontrib><creatorcontrib>Wiebe, L.I.</creatorcontrib><title>Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models—I. 6-[ 3H]-5-fluorouracil</title><title>International journal of nuclear medicine & biology</title><addtitle>Int J Nucl Med Biol</addtitle><description>The differential tissue distribution and urinary excretion of small intravenous doses (4 μg kg
−1) of 6-[
3H]-5-fluorouracil have been studied in two strains of mice bearing transplantable tumors. The subcutaneous Lewis Lung carcinoma and the solid Ehrlich Ascites carcinoma both retained less than 1.5% of the dose, and for all tissues assayed the tumor: blood ratios for radioactivity were 11:1 or less. Approximately 75% of the injected dose was excreted during the first 12 h. Urinary excretion was resolved using a two-compartmental model. The half-life of the fast component was just over 1 h while that for the slow component was in excess of 10 days.</description><subject>Animals</subject><subject>Carcinoma, Ehrlich Tumor - metabolism</subject><subject>Carcinoma, Ehrlich Tumor - urine</subject><subject>Fluorouracil - metabolism</subject><subject>Fluorouracil - urine</subject><subject>Half-Life</subject><subject>Lung Neoplasms - metabolism</subject><subject>Lung Neoplasms - urine</subject><subject>Male</subject><subject>Mice</subject><subject>Models, Biological</subject><subject>Neoplasm Transplantation</subject><subject>Neoplasms, Experimental - metabolism</subject><subject>Neoplasms, Experimental - urine</subject><subject>Pyrimidine Nucleosides - metabolism</subject><subject>Pyrimidine Nucleosides - urine</subject><subject>Time Factors</subject><subject>Tritium</subject><issn>0047-0740</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1979</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kLlKBTEUhlO4L29gkUq0GM1syaQRRNxAsNFKJJxJTiCamVyTG8HOh_AJfRLnekWwsTrwb3A-QvZKdlSykh8z1oiCiYYdCHkoGWN1Ua2QzV95g2yl9MRY1TUtXydrjeiEqDZJvstDiDTP5vCMNFgawbjgoUePhs7eohuccSPSHhImCuMfcczaY0jOTJYbJ9cN4OkQDPr0-f5xfUR58UDrq8eiLazPIYYcQTu_Q1Yt-IS7P3eb3F-c351dFTe3l9dnpzeFrkQ5L7Q2UgA3ErCzAmrQVspW1n1rreQWmhZr5Ka2vW3LukUQgrXa8o5L1jFo6m2yv9ydxfCSMc3V4JJG72HEkJMSDZeSy2oKNsugjiGliFbNpichvqmSqQVgtSCpFiSVkOobsFrU9n72cz-g-S0t6U72ydKecOCrw6iSdjhqNC6inisT3P_7Xy85jpA</recordid><startdate>1979</startdate><enddate>1979</enddate><creator>Abrams, D.N.</creator><creator>Knaus, E.E.</creator><creator>Wiebe, L.I.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1979</creationdate><title>Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models—I. 6-[ 3H]-5-fluorouracil</title><author>Abrams, D.N. ; Knaus, E.E. ; Wiebe, L.I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c271t-ccd97a6d9ae8f7a3acf99593b5ff96fa45e3e6d3fbf5135ea7705cf6869080a43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1979</creationdate><topic>Animals</topic><topic>Carcinoma, Ehrlich Tumor - metabolism</topic><topic>Carcinoma, Ehrlich Tumor - urine</topic><topic>Fluorouracil - metabolism</topic><topic>Fluorouracil - urine</topic><topic>Half-Life</topic><topic>Lung Neoplasms - metabolism</topic><topic>Lung Neoplasms - urine</topic><topic>Male</topic><topic>Mice</topic><topic>Models, Biological</topic><topic>Neoplasm Transplantation</topic><topic>Neoplasms, Experimental - metabolism</topic><topic>Neoplasms, Experimental - urine</topic><topic>Pyrimidine Nucleosides - metabolism</topic><topic>Pyrimidine Nucleosides - urine</topic><topic>Time Factors</topic><topic>Tritium</topic><toplevel>online_resources</toplevel><creatorcontrib>Abrams, D.N.</creatorcontrib><creatorcontrib>Knaus, E.E.</creatorcontrib><creatorcontrib>Wiebe, L.I.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of nuclear medicine & biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abrams, D.N.</au><au>Knaus, E.E.</au><au>Wiebe, L.I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models—I. 6-[ 3H]-5-fluorouracil</atitle><jtitle>International journal of nuclear medicine & biology</jtitle><addtitle>Int J Nucl Med Biol</addtitle><date>1979</date><risdate>1979</risdate><volume>6</volume><issue>2</issue><spage>97</spage><epage>101</epage><pages>97-101</pages><issn>0047-0740</issn><abstract>The differential tissue distribution and urinary excretion of small intravenous doses (4 μg kg
−1) of 6-[
3H]-5-fluorouracil have been studied in two strains of mice bearing transplantable tumors. The subcutaneous Lewis Lung carcinoma and the solid Ehrlich Ascites carcinoma both retained less than 1.5% of the dose, and for all tissues assayed the tumor: blood ratios for radioactivity were 11:1 or less. Approximately 75% of the injected dose was excreted during the first 12 h. Urinary excretion was resolved using a two-compartmental model. The half-life of the fast component was just over 1 h while that for the slow component was in excess of 10 days.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>478772</pmid><doi>10.1016/0047-0740(79)90003-2</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0047-0740 |
ispartof | International journal of nuclear medicine & biology, 1979, Vol.6 (2), p.97-101 |
issn | 0047-0740 |
language | eng |
recordid | cdi_proquest_miscellaneous_74699692 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Animals Carcinoma, Ehrlich Tumor - metabolism Carcinoma, Ehrlich Tumor - urine Fluorouracil - metabolism Fluorouracil - urine Half-Life Lung Neoplasms - metabolism Lung Neoplasms - urine Male Mice Models, Biological Neoplasm Transplantation Neoplasms, Experimental - metabolism Neoplasms, Experimental - urine Pyrimidine Nucleosides - metabolism Pyrimidine Nucleosides - urine Time Factors Tritium |
title | Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models—I. 6-[ 3H]-5-fluorouracil |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T15%3A36%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tumor%20uptake%20of%20radiolabeled%20pyrimidine%20bases%20and%20pyrimidine%20nucleosides%20in%20animal%20models%E2%80%94I.%206-%5B%203H%5D-5-fluorouracil&rft.jtitle=International%20journal%20of%20nuclear%20medicine%20&%20biology&rft.au=Abrams,%20D.N.&rft.date=1979&rft.volume=6&rft.issue=2&rft.spage=97&rft.epage=101&rft.pages=97-101&rft.issn=0047-0740&rft_id=info:doi/10.1016/0047-0740(79)90003-2&rft_dat=%3Cproquest_cross%3E74699692%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=74699692&rft_id=info:pmid/478772&rft_els_id=0047074079900032&rfr_iscdi=true |